Skip to Content
MilliporeSigma
All Photos(2)

Key Documents

94509

Sigma-Aldrich

IgGZERO

for cleaving 5 mg IgG, 5000 U/vial

Synonym(s):

EndoS from Streptococcus pyogenes

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
EC Number:
UNSPSC Code:
12352204

recombinant

expressed in E. coli

form

powder

specific activity

5000 U/vial

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

Unit Definition

One unit is defined as the amount of enzyme required to remove 95% of 1 ug of human IgG Fc glycans in 30 minutes at 37°C, pH 7.2 as monitored by SDS-PAGE.

Analysis Note

SDS gel electrophoresis ≥ 95 % purity

Legal Information

IgGZERO is a trademark of Genovis AB

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Maria Allhorn et al.
Annals of the New York Academy of Sciences, 1173, 664-669 (2009-09-18)
The enzyme EndoS from Streptococcus pyogenes is an immunomodulatory molecule hydrolyzing the conserved glycans in the effector part of immunoglobulin G (IgG). EndoS is remarkably specific for IgG, and hydrolysis has profound effects on IgG effector functions. EndoS pretreatment of
Patrick R Romano et al.
Biochemical and biophysical research communications, 414(1), 84-89 (2011-09-29)
Changes in glycosylation have long been associated with disease. While there are many methods to detect changes in glycosylation, plant derived lectins are often used to determine changes on specific proteins or molecules of interest. One change in glycosylation that
Andrew M Goetze et al.
Glycobiology, 22(2), 221-234 (2011-09-21)
Glycation of immunoglobulin G (IgG) can result from incubation with a reducing sugar in vitro or during circulation in vivo. Upon injection of a recombinantly produced human therapeutic IgG into humans, changes in the glycation levels could be observed as
Andrew M Goetze et al.
Molecular immunology, 49(1-2), 338-352 (2011-09-29)
A new method for simultaneously screening allelic variants and certain Fc modifications on endogenous human IgG1 and IgG2 directly from blood samples is described. The IdeS endoproteinase was used to cleave IgG in serum to generate Fc, which, after denaturation
Midori Umekawa et al.
Biochimica et biophysica acta, 1800(11), 1203-1209 (2010-07-22)
An efficient method for synthesizing homogenous glycoproteins is essential for elucidating the structural and functional roles of glycans of glycoproteins. We have focused on the transglycosylation activity of endo-ß-N-acetylglucosaminidase from Mucor hiemalis (Endo-M) as a tool for glycoconjugate syntheses, since

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service